Location History:
- Philadelphia, PA (US) (2015)
- Providence, RI (US) (2018 - 2024)
- Cambridge, MA (US) (2021 - 2024)
Company Filing History:
4 out of 4,455 
1 out of 16,338 
1 out of 2,509 
Years Active: 2015-2024
Title: Omar Khaled Ahmad: Innovator in Pharmaceutical Sciences
Introduction
Omar Khaled Ahmad is a distinguished inventor based in Providence, RI (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel therapeutic compounds. With a total of 6 patents to his name, Ahmad's work focuses on innovative solutions for treating serious medical conditions, including cancer.
Latest Patents
Among his latest patents, Ahmad has developed calicheamicin derivatives and antibody drug conjugates. This invention is directed to novel calicheamicin derivatives that serve as payloads in antibody-drug conjugates (ADCs). These compounds are crucial for creating pharmaceutical compositions aimed at treating pathological conditions such as cancer. Another notable patent involves toll-like receptor agonists, which relates to imidazo-pyridinyl compounds. These compounds and their pharmaceutically acceptable salts are designed for use in treating abnormal cell growth, including cancer, in patients.
Career Highlights
Throughout his career, Omar Khaled Ahmad has worked with prominent companies in the pharmaceutical industry. He has been associated with Pfizer Corporation and E.I. du Pont de Nemours and Company, where he has contributed to various innovative projects. His experience in these leading organizations has helped him refine his skills and expand his knowledge in drug development.
Collaborations
Ahmad has collaborated with several talented individuals in his field, including Andrew Fensome and Erik Alphie LaChapelle. These collaborations have fostered a creative environment that has led to the advancement of new ideas and technologies in pharmaceutical research.
Conclusion
Omar Khaled Ahmad is a notable inventor whose work in pharmaceutical sciences has the potential to impact the treatment of cancer and other serious diseases. His innovative patents and collaborations highlight his commitment to advancing medical research and improving patient outcomes.